.
MergerLinks Header Logo

New Deal


Announced

Completed

RECEPTOS INC. / CELGENE CORPORATION / Public / Acquisition / £4639m

Financials

Edit Data
Transaction Value£4,639m
Consideration Type-
Capital Owned-
Capital Bid For100%
EV/Sales-
EV/EBITDA-
Share Price Premium-
One Off Charge-

Sources

Edit

Tags

Edit

treatment development

pharmaceuticals

biotechnology

Biotechnology

Acquisition

Public

Completed

Friendly

Single Bidder

United States

Synopsis

Edit

Sale of Receptos, a clinical-stage biopharmaceutical company, to Celgene.

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US